APLS Jan 2025 30.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:08AM EDT. Market open.
| Previous close | 16.80 |
| Open | 16.80 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 30.00 |
| Expiry date | 2025-01-17 |
| Day's range | 16.80 - 16.80 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- GuruFocus.com
Apellis Pharmaceuticals Inc (APLS) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue ...
Discover how Apellis Pharmaceuticals Inc navigated Q1 2024 with significant revenue increases and strategic advancements despite competitive challenges.
ZacksApellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat
Apellis (APLS) reports first-quarter 2024 results, wherein earnings match the Zacks Consensus Estimate and revenues beat the same, driven by strong sales of Syfovre.
ZacksApellis Pharmaceuticals (APLS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Apellis Pharmaceuticals (APLS) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
© 2024 Yahoo. All rights reserved.